Health Tech

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences

In this month’s episode, we dive into some recent executive appointments occurring in the healthcare world, as well as layoffs affecting the industry. We also hear from Leslie Orne, who recently became the new CEO of Trinity Life Sciences, which provides consulting services and technology solutions to life sciences firms looking to commercialize their product.

The MedCity Moves Podcast is back with another episode. We discuss some of the executive appointments occurring in the healthcare sector over the past month — including new leaders at AHIP, GoodRx and Phoenix Children’s. We also dive into some layoffs affecting the industry — such the recent rounds of job cuts at Biogen, Jefferson Health and TytoCare.

For this episode’s guest interview, we are joined by Leslie Orne, who just became the new CEO of Trinity Life Sciences. Her company, which she has been with for over 20 years, provides consulting services and technology solutions to life sciences firms looking to commercialize their product.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

To hear the full episode and learn what Orne thinks is in store for AI innovation in the life sciences space, click here: